Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

06 May 2022 Evaluate

Zydus Lifesciences has informed that it enclosed Press release dated May 6, 2022 titled 'Zydus receives tentative approval from USFDA for Selexipag Tablets'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.30
Dr. Reddys Labs. 1375.20
Cipla 1401.50
Lupin 2008.35
Zydus Lifesciences 1204.90
View more..